Nitric oxide and cyclic GMP signaling (43950A)

Experimental Biology and Medicine

Volumn 211, Issue 1, 1996, Pages 1-6

  Mcdonald, Lee J ^a   Murad, Ferid ^a  

^a Molecular Geriatrics Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC GMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; GUANYLATE CYCLASE; ION CHANNEL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

CONFERENCE PAPER; PROTEIN TARGETING; REGULATORY MECHANISM; SECOND MESSENGER; SIGNAL TRANSDUCTION; SMOOTH MUSCLE RELAXATION; THROMBOCYTE FUNCTION;

ANIMALS; CYCLIC GMP; GUANYLATE CYCLASE; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOLS;

EID: 0030032311     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Murad F. Cyclic guanosine monophosphate as a mediator of vasodilation. J Clin Invest 78:1-5, 1986.
2. Murad F. Regulation of cytosolic guanylyl cyclase by nitric oxide: The NO-cyclic GMP signal transduction system. Adv Pharmacol 26:19-33, 1994.
3. Murad F, Förstermann U, Nakane M, Pollock J, Tracey R, Matsumoto T, Buechler W. The nitric oxide-cyclic GMP signal transduction system for intracellular and intercellular communication. Adv Second Messenger Phosphoprotein Res 28:101-109, 1993.
4. 2+/calmodulin-regulated nitric oxide synthases. Cell Calcium 13:427-434, 1992.
5. Schmidt HHHW, Lohmann SM, Walter U. The nitric oxide and cGMP signal transduction system: Regulation and mechanism of action. Biochim Biophys Acta 1178:153-175, 1993.
6. Marietta MA Nitric oxide synthase: Aspects concerning structure and catalysis. Cell 78:927-930, 1994.
7. Nathan C, Xie Q. Nitric oxide synthases: roles, tolls, and controls. Cell 78:915-918, 1994.
8. Bredt S, Snyder SH. Nitric oxide, a novel neuronal messenger. Neuron 8:3-11, 1992.
9. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 6:3051-3064, 1992.
10. Schmidt HHHW, Walter U. NO at work. Cell 78:919-925, 1994.
11. Feldman PL, Griffith OW, Stuehr DJ. The surprising life of nitric oxide. Chem Engin News December 20:26-38, 1993.
12. Pollock JS, Föstermann U, Mitchell JA, Warner TD, Schmidt HHHW, Nakane M, Murad F. Purification and characterization of particulate EDRF synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci USA 88:10480-10484, 1991.
13. Stamler JS, Singel DJ, Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science 258:1989-1902, 1992.
14. Stamler JS. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 78:931-936, 1994.
15. Braughler JM, Mittal CK, Murad F. Effect of thiols, sugars, and proteins on nitric oxide activation of guanylate cyclase. J Biol Chem 354:12450-12454, 1979.
16. Katsuki S, Arnold W, Mittal CK, Murad F. Stimulation of guanyiate cyctase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J Cyclic Nucl Res 3:23-35, 1977
17. Arnold WP, Mittal CK, Katsuki S, Murad F. Nitric oxide activates guanylate cyclase and increases guanosine 3′,5′-monophosphate levels in various tissue preparations. Proc Natl Acad Sci USA 74:3203-3207, 1977.
18. Katsuki S, Arnold WP, Murad F. Effect of sodium nitroprusside, nitroglycerin and sodium azide on levels of cyclic nucleotides and mechanical activity of various tissues. J Cyclic Nucl Res 3:239-247, 1977
19. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 3:2007-2018, 1989.
20. Kimura H, Murad F. Evidence for two different forms of guanylate cyclase in rat heart. J Biol Chem 249:6910-6919, 1974.
21. Kuno T, Andresen JW, Kamisake Y, Waldman SA, Chang LY, Saheki S, Leitman DC, Nakane M, Murad F. Co-purification of an atrial natriuretic factor receptor and particulate guanylate cyclase from rat lung. J Biol Chem 261:5817-5823, 1986.
22. Schulz S, Yuen PST, Garbers DL. The expanding family of guanylyl cyclases. Trends Pharmacol Sci 12:116-120, 1991.
23. Garbers DL. Guanylyl cyclase receptors and their endocrine, paracrine, and autocrine ligands. Cell 71:1-4, 1992.
24. Nakane M, Murad F. Cloning of guanylyl cyclase isoforms. Adv Pharmacol 26:7-18, 1994.
25. Leitman DC, Waldman SA, Murad F. Regulation of particulate guanylate cyclase by natriuretic peptides and Escherichia coli heat-stable enterotoxin. Adv Pharmacol 26:67-86, 1994.
26. Kamisaki Y, Saheki S, Nakane M, Palmieri J, Kuno T, Chang B, Waldman SA, Murad F. Soluble guanylate cyclase from rat lung exists as a heterodimer. J Biol Chem 261:7236-7241, 1986.
27. Buechler WA, Nakane M, Murad F. Expression of soluble guanylate cyclase activity requires both enzyme subunits. Biochem Biophys Res Commun 174:351-357, 1991.
28. Lewicki JA, Brandwein HJ, Mittal CK, Arnold WP, Murad F. Properties of purified soluble guanylate cyclase activated by nitric oxide and sodium nitroprusside. J Cyclic Nucl Res 8:17-25, 1982.
29. Wedel B, Humbert P, Hanteneck C, Foerster J, Malkewitz J, Böhme E, Schultz G, Koesling D. Mutation of his-105 in the β1 subunit yields a nitric oxide-insensitive form of soluble guanylyl cyclase. Proc Natl Acad Sci USA 91:2592-2596, 1994.
30. Brandwein HJ, Lewicki JA, Murad F. Reversible inactivation of guanylate cyclase by mixed disulfide formation. J Biol Chem 256:2958-2962, 1981.
31. Kamisaki Y, Waldman SA, Murad F. The involvement of catalytic site thiol groups in the activation of soluble guanylate cyclase by sodium nitroprusside. Arch Biochem Biophys 251:709-714, 1986.
32. Lincoln TM, Cornwell TL. Intracellular cyclic GMP receptor proteins. FASEB J 7:328-338, 1993.
33. Mittal CK, Braughter JM, Ichihara K, Murad F. Synthesis of adenosine 3′,5′-monophosphate by guanylate cyclase: A new pathway for its formation. Biochim Biophys Acta 585:333-342, 1979.
34. Sonnenberg WK, Beavo J. Cyclic GMP and regulation of cyclic nucleotide hydrolases. Adv Pharmacol 26:87-114, 1994.
35. Hirata M, Murad F. Interrelationships of cyclic GMP, inositol phosphates, and calcium. Adv Pharmacol 26:195-216, 1994.
36. Vaandragen AB, DeJonge HR. Effect of cyclic GMP on intestinal transport. Adv Pharmacol 26:253-284, 1994.
37. 2+ current: Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. J Biol Chem 286:26286-26295, 1993.
38. Lugnier C, Komas N. Modulation of vascular cyclic nucleotide phosphodiesterases by cyclic GMP: Role in vasodilation. Eur Heart J 14(Suppl 1): 141-148, 1993.
39. Maurice DH, Haslam RJ. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: Inhibition of cyclic AMP breakdown by cyclic GMP. Mol Pharmacol 37:671-681, 1990.
40. Hirata M, Kohse KP, Chang C-H, Ikebe T, Murad F. Mechanism of cyclic GMP inhibition of inositol phosphate formation in rat aorta segments and cultured bovine aortic smooth muscle cells. J Biol Chem 265:1268-1273, 1990.
41. 2+ in sea urchin eggs by stimulating cyclic ADP-ribose synthesis. Nature 365:456-459, 1993.
42. Berridge MJ. A tale of two messengers. Nature 365:388-389, 1993.